Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Prospective, Randomized Controlled Matriarch Trial Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care Versus SOC Alone of Nonhealing Diabetic Foot and Venous Leg Ulcers

NCT06562296 is registered in ClinicalTrials.gov with Cellution Biologics as lead sponsor.

NCT NCT06562296
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06562296 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Prospective, Randomized Controlled Matriarch Trial Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care Versus SOC Alone of Nonhealing Diabetic Foot and Venous Leg Ulcers
Lead sponsor
Cellution Biologics
Phase
Phase 4
Overall status
Completed
Start date
October 14, 2024
Completion date
January 16, 2026
Enrollment
292 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic foot ulcer, venous leg ulcer